Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatic neoplasm
ADR ID BADD_A02010
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
09.04.03      Hepatobiliary neoplasms NEC
09.04.03.001      Hepatic neoplasm
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.07      Hepatobiliary neoplasms malignant and unspecified
16.07.03      Hepatobiliary neoplasms malignancy unspecified
16.07.03.001      Hepatic neoplasm
Description Tumors or cancer of the LIVER. [MeSH]
MedDRA Code 10019695
MeSH ID D008113
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatic neoplasia | Hepatic neoplasm | Hepatic neoplasm NOS | Liver neoplasm | Liver tumor | Liver tumor NOS | Liver tumour NOS | Neoplasm liver | Tumor liver | Liver tumour | Tumour liver | Liver Neoplasms | Neoplasms, Hepatic | Neoplasms, Liver | Liver Neoplasm | Neoplasm, Liver | Hepatic Neoplasms | Hepatic Neoplasm | Neoplasm, Hepatic | Cancer of Liver | Hepatocellular Cancer | Cancers, Hepatocellular | Hepatocellular Cancers | Hepatic Cancer | Cancer, Hepatic | Cancers, Hepatic | Hepatic Cancers | Liver Cancer | Cancer, Liver | Cancers, Liver | Liver Cancers | Cancer of the Liver | Cancer, Hepatocellular
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01922Regorafenib0.000224%
BADD_D01933Ribavirin0.007912%
BADD_D01938Rifaximin0.000482%
BADD_D02029Sitagliptin0.000053%
BADD_D02053Sofosbuvir0.000282%
BADD_D02058Sorafenib0.000168%
BADD_D02100Sunitinib0.000336%
BADD_D02154Tenofovir0.001939%
BADD_D02170Testosterone--
BADD_D02171Testosterone cypionate--
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02331Valsartan0.000185%
BADD_D02344Vemurafenib0.000112%
BADD_D02345Venetoclax0.000168%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02412Octreotide0.000931%
BADD_D02483Ribociclib0.000168%
BADD_D02510Rucaparib0.000112%
BADD_D02591Ripretinib0.000168%
The 2th Page    First    Pre   2    Total 2 Pages